EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Molecular pathologies and therapies for Pelizaeus-Merzbacher disease

Ken Inoue

Brain and Development · 2025

DOI: 10.1016/j.braindev.2025.104383 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain and Development, 2025. Verfasst von Ken Inoue. Beteiligte Einrichtung: Medical Genome Center, National Center of Neurology and Psychiatry (NCNP), Japan. Electronic address: kinoue@ncnp.go.jp. Hauptthemen laut MEDLINE: Pelizaeus-Merzbacher Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pelizaeus-Merzbacher DiseaseHumansMyelin Proteolipid ProteinAnimalsMutationGenetic Therapy

Stichwörter der Autor:innen

AAVASOGene therapyHypomyelinating leukodystrophyMolecular mechanismsMolecular therapies

Substanzen

Myelin Proteolipid ProteinPLP1 protein, human

Autor:innen und Institutionen

  • Medical Genome Center, National Center of Neurology and Psychiatry (NCNP), Japan. Electronic address: kinoue@ncnp.go.jp.

Förderung

  • Japan Agency for Medical Research and Development
  • Ministry of Health, Labour and Welfare

Zitieren

APA

Inoue, K. (2025). Molecular pathologies and therapies for Pelizaeus-Merzbacher disease. Brain and Development. https://doi.org/10.1016/j.braindev.2025.104383

Vancouver

Inoue K. Molecular pathologies and therapies for Pelizaeus-Merzbacher disease. Brain and Development. 2025. doi:10.1016/j.braindev.2025.104383

BibTeX
@article{Inoue2025,
  author = {Inoue, Ken},
  title = {Molecular pathologies and therapies for Pelizaeus-Merzbacher disease},
  journal = {Brain and Development},
  year = {2025},
  doi = {10.1016/j.braindev.2025.104383}
}
Kostenlos starten →